Headlines about Perrigo (NYSE:PRGO) have been trending neutral this week, according to InfoTrie. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Perrigo earned a news sentiment score of 0.22 on their scale. InfoTrie also gave headlines about the company an news buzz score of 10 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock’s share price in the immediate future.
Here are some of the headlines that may have effected Perrigo’s analysis:
- Assessing GW Pharmaceuticals’ Year-to-Date Performance (finance.yahoo.com)
- Perrigo Company PLC (PRGO) VP Todd W. Kingma Buys 3,200 Shares (americanbankingnews.com)
- Murray S. Kessler Purchases 15,683 Shares of Perrigo Company PLC (PRGO) Stock (americanbankingnews.com)
- Perrigo Company PLC (PRGO) EVP Purchases $245,739.00 in Stock (americanbankingnews.com)
- Perrigo Co Plc (PRGO) CEO Murray S Kessler Bought $1 million of Shares (gurufocus.com)
A number of equities research analysts recently issued reports on PRGO shares. Canaccord Genuity set a $90.00 target price on Perrigo and gave the company a “buy” rating in a research note on Friday, August 17th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $107.00 target price on shares of Perrigo in a research note on Wednesday, July 18th. Jefferies Financial Group reaffirmed a “hold” rating and issued a $73.00 target price on shares of Perrigo in a research note on Friday, August 10th. Royal Bank of Canada reduced their target price on Perrigo from $89.00 to $67.00 and set a “hold” rating on the stock in a research note on Friday, August 10th. Finally, Stifel Nicolaus cut their price target on Perrigo from $92.00 to $87.00 and set a “hold” rating for the company in a report on Friday, August 10th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $87.80.
Shares of PRGO stock traded up $1.19 on Friday, reaching $64.07. 2,559,887 shares of the stock were exchanged, compared to its average volume of 1,279,278. The company has a market cap of $10.11 billion, a price-to-earnings ratio of 13.00, a PEG ratio of 2.39 and a beta of 0.66. The company has a quick ratio of 1.23, a current ratio of 1.81 and a debt-to-equity ratio of 0.52. Perrigo has a 1-year low of $62.74 and a 1-year high of $95.93.
Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Thursday, November 8th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.04. Perrigo had a return on equity of 11.92% and a net margin of 4.77%. The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period in the prior year, the firm earned $1.39 EPS. The firm’s quarterly revenue was down 8.0% compared to the same quarter last year. As a group, analysts expect that Perrigo will post 4.85 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 18th. Shareholders of record on Friday, November 30th will be given a $0.19 dividend. The ex-dividend date of this dividend is Thursday, November 29th. This represents a $0.76 dividend on an annualized basis and a yield of 1.19%. Perrigo’s payout ratio is currently 15.42%.
In other news, EVP Svend Andersen acquired 7,200 shares of the firm’s stock in a transaction on Tuesday, August 14th. The stock was bought at an average cost of $69.43 per share, with a total value of $499,896.00. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Todd W. Kingma acquired 3,200 shares of the firm’s stock in a transaction on Friday, November 9th. The stock was purchased at an average cost of $63.99 per share, with a total value of $204,768.00. Following the completion of the transaction, the vice president now owns 23,587 shares in the company, valued at $1,509,332.13. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 29,983 shares of company stock valued at $1,950,822. 6.90% of the stock is currently owned by corporate insiders.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Article: Understanding Relative Strength Index
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.